EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Pleuropneumonectomy in the treatment of malignant pleural mesothelioma


, : Pleuropneumonectomy in the treatment of malignant pleural mesothelioma. Chest 116(6 Suppl): 450s-454s

Malignant pleural mesothelioma (MPM) is predominantly a local/regional disease that results in a survival time that ranges from 4 to 12 months without treatment. Single-modality therapy using surgery, chemotherapy, or radiotherapy alone is largely ineffective. The objective of the study was presentation of the use of pleuropneumonectomy in a multimodality treatment setting and the results. Didactic presentation. Academic tertiary-care hospital. One hundred eighty-three patients who underwent multimodality therapy. Of all the single-modality treatment approaches, pleuropneumonectomy has been associated most consistently with long-term disease-free survival and has provided the greatest amount of tumor cytoreduction. The technique of pleuropneumonectomy traditionally has been linked with high perioperative mortality and morbidity when compared with that of other cytoreductive techniques such as pleurectomy/decortication. Recently, improvements in operative mortality (< 5%) have been reported, largely due to improvements in patient selection and perioperative management. Multimodality therapy, including chemotherapy, radiotherapy, and extrapleural pneumonectomy, was used to treat patients. Outcomes were presented for 183 patients with MPM who underwent multimodality therapy. With the development of multimodality therapy, pleuropneumonectomy followed by sequential chemotherapy and radiotherapy has demonstrated a significant survival benefit, especially for patients who have epithelial tumor histology, tumor-free resection margins, and tumor-free extrapleural node status.


Accession: 047002625

PMID: 10619506

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Takagi, K., 2008: Pleuropneumonectomy: an effective treatment modality for malignant pleural mesothelioma?. Annals of Thoracic and Cardiovascular Surgery 14(3): 135-137

Takagi, K., 2010: What is the role of pleuropneumonectomy in malignant pleural mesothelioma?. In this report, the results of conventional pleuropneumonectomy in malignant diffuse mesothelioma are reviewed, and the role of this aggressive surgery in multidisciplinary treatment is discussed. The surgical results may improve owing to recent a...

Sato K.; Maeno H.; Dambara T.; E.A., 1988: A case of diffuse pleural malignant mesothelioma treated with pleuropneumonectomy. The patient was a 67 year-old man suffering from left chest pain and left anterior chest swelling. Chest X-ray examination showed diffuse and irregular left pleural thickening. Needle and open biopsy from left anterior chest mass revealed diffuse...

Krayenbuehl, Jôme.; Hartmann, M.; Lomax, A.J.; Kloeck, S.; Hug, E.B.; Ciernik, I.Frank., 2010: Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy. To perform comparative planning for intensity-modulated radiotherapy (IMRT) and proton therapy (PT) for malignant pleural mesothelioma after radical surgery. Eight patients treated with IMRT after extrapleural pleuropneumonectomy (EPP) were replan...

Bonnette, P.; Heckly, G.Bourg.; Villette, S.; Fragola, A., 2002: Intraoperative photodynamic therapy after pleuropneumonectomy for malignant pleural mesothelioma. Chest 122(5): 1866-7; Author Reply 1867

Krayenbuehl, Jôme.; Oertel, S.; Davis, J.Bernard.; Ciernik, I.Frank., 2007: Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy. Purpose: The optimal technique for postoperative radiotherapy (RT) after extrapleural pleuropneumonectomy (EPP) of malignant pleural mesothelioma (MPM) remains debated.Methods and Materials: The data from 8 right-sided and 9 left-sided consecutive...

Schouwink, J., H.; Bass, P., 2002: Intraoperative photodynamic therapy after pleuropneumonectomy for malignant pleural mesothelioma: Response. Chest 122(5): 1867

Hahnloser, P.; Geroulanos, S., 1976: Reconstruction of the diaphragm with a pericardial flap after radical pleuropneumonectomy for malignant pleural mesothelioma. Pleuropneunomectomy with resection of the diaphragm only offers acceptable therapeutic results in patients with multifocal malignant mesothelioma of the pleura. Diaphragmatic replacement on the right side can be satisfactorily achieved by fixation...

Milazzo, M.; Magrone, G.; Romanelli, A.; Ronconi, G.; Gallotta, E.; Sterzi, S., 2008: Evaluation of the rehabilitation program in a patient submitted to pleuropneumonectomy for malignant pleural mesothelioma. The purpose of this study is to test a rehabilitation program for the patients with malignant pleural mesothelioma (MPM) subordinates to pleuropneumonectomy. A single patient was evaluated at baseline (TI) and at the end of the pulmonary rehabilit...

Schouwink, H.; Rutgers, E.T.; Van Der Sijp, J.; Oppelaar, H.; Van Zandwijk, N.; Van Veen, R.; Burgers, S.; Stewart, F.A.; Zoetmulder, F.; Baas, P., 2001: Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma. Does finding and toxicity results. Objective: To determine the optimal administered dose of meta-tetrahydroxyphenylchlorin (mTHPC) for intraoperative photodynamic therapy (IPDT) in resected malignant pleural mesothelioma (MPM). The primary objective of this combination treatment wa...